A Study of Intrathecal Hydromorphone for Pediatric Idiopathic Scoliosis Repair

Overview

About this study

The purpose of this this study is to perform a dose finding study in our adolescent patients undergoing idiopathic scoliosis repair to identify the ED90 dose for ITH.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Undergoing spinal surgery with a posterior approach for idiopathic scoliosis.

Exclusion Criteria:

  • Patients with pre-surgical elevated pain scores (≥ 3/10 on Numeric Rating Scale (NRS)), history of chronic pain, or pre-surgical opioid use will not be included.
  • Patients with contraindications to spinal anesthesia (anatomical abnormality or elevated bleeding or infection risks) will not be included.
  • Patients for whom the protocol is violated (inability to perform postoperative data collection), or the study/procedure was aborted will not be included in analysis.

Eligibility last updated 3/22/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kathryn Handlogten, M.D.

Contact us for the latest status

Contact information:

Kathryn Handlogten M.D.

(507) 255-6219

Handlogten.Kathryn@mayo.edu

More information

Publications

Publications are currently not available